![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](om6072contents.gif)
Acta Cryst. (2002). E58, o13-o15 [ doi:10.1107/S1600536801020475 ]
Abstract: In this study, we report on the X-ray diffraction analysis of the pentapeptide, Boc-Tyr-D-Ala-Gly-(NMe-Phe)-(Met-O-Me), C35H49N5O9S·1.125H2O. This is a protected intermediate in the solution phase synthesis of metkephamid (LY127,623), Tyr-D-Ala-Gly-NMe-Phe-Met-NH2. The peptide crystallizes in the monoclinic space group C2 with two peptide molecules and three solvent (water) molecules in the asymmetric unit. The peptide has an extended conformation similar to other Met-enkephalins.
Online 8 December 2001
Copyright © International Union of Crystallography
IUCr Webmaster